Diabetes
Latest News
The costs and benefits of SGLT2 inhibitors & GLP-1 RAs
The price tags on these drugs are the biggest barrier to their use.
Latest News
BMI screening trigger for type 2 diabetes is unreliable for at-risk black, Hispanic adults
SAN FRANCISCO – One risk factor should trigger screening in normal weight.
Latest News
Low-fat dairy associated with decreased risk of type 2 diabetes
SAN FRANCISCO – An indicator of healthy living, or a true effect?
Feature
Using Obamacare authority, Trump aims to shift dialysis care to patients’ homes
The plan aims to increase the number of patients getting dialysis at home and double the annual number of kidneys available for transplant.
Conference Coverage
Type 2 diabetes is particularly devastating in adolescents
SAN FRANCISCO – “These kids have problems you’d expect in their grandparents.” – Dr....
Latest News
SGLT2 inhibitors, GLP-1 RAs are effective, but costly in T2D
Latest News
Metformin linked to lower dementia risk in black patients
Black patients younger than 75 years fared better on first-line metformin monotherapy than they did on sulfonylurea monotherapy.
From the Journals
Mortality caused by chronic liver disease in setting of diabetes continues to rise
The findings underscore the need to better address nonalcoholic fatty liver disease and end-stage liver disease among individuals with diabetes....
Conference Coverage
VOC-sniffing necklace may support early detection of hypoglycemia
SAN FRANCISCO – Same trick as diabetes alert dogs – minus the pup.
Conference Coverage
New findings cast more doubt on ‘fat-but-fit’ theory
Conference Coverage
CAROLINA findings reaffirm linagliptin’s safety, free glimepiride of CV-risk stigma
SAN FRANCISCO – Concerns remain around glimepiride-related weight gain and hypoglycemia.